These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17116730)

  • 1. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
    Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
    Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor blood volume determination by using susceptibility-corrected DeltaR2* multiecho MR.
    Persigehl T; Wall A; Kellert J; Ring J; Remmele S; Heindel W; Dahnke H; Bremer C
    Radiology; 2010 Jun; 255(3):781-9. PubMed ID: 20501715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
    Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
    Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of bevacizumab-induced antiangiogenic treatment effects by "steady state" ultrasmall superparamagnetic iron oxide particles magnetic resonance imaging using robust multiecho ΔR2* relaxometry.
    Ring J; Persigehl T; Remmele S; Heindel W; Dahnke H; Bremer C
    Invest Radiol; 2011 May; 46(5):326-30. PubMed ID: 21358548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission.
    Chen BB; Hsu CY; Yu CW; Hou HA; Liu CY; Wei SY; Chou WC; Tien HF; Shih TT
    Radiology; 2011 Mar; 258(3):821-31. PubMed ID: 21212370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study.
    Taylor SA; Punwani S; Rodriguez-Justo M; Bainbridge A; Greenhalgh R; De Vita E; Forbes A; Cohen R; Windsor A; Obichere A; Hansmann A; Rajan J; Novelli M; Halligan S
    Radiology; 2009 May; 251(2):369-79. PubMed ID: 19276323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
    Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
    Franiel T; Lüdemann L; Rudolph B; Rehbein H; Stephan C; Taupitz M; Beyersdorff D
    Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
    Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
    Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
    Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
    Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings.
    Baur A; Bartl R; Pellengahr C; Baltin V; Reiser M
    Cancer; 2004 Dec; 101(11):2599-604. PubMed ID: 15503306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of antiangiogenic treatment efficacy by iron oxide enhanced parametric magnetic resonance imaging.
    Persigehl T; Matuszewski L; Kessler T; Wall A; Meier N; Ebert W; Berdel WE; Heindel W; Mesters R; Bremer C
    Invest Radiol; 2007 Dec; 42(12):791-6. PubMed ID: 18007150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis.
    Thomassin-Naggara I; Bazot M; Daraï E; Callard P; Thomassin J; Cuenod CA
    Radiology; 2008 Jul; 248(1):148-59. PubMed ID: 18458244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
    Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
    Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.